FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

26658011000001100: Azapress 50mg tablets (Ennogen Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83394001000001110 Azapress 50mg tablets (Ennogen Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83394101000001111 Azapress 50mg tablets (Ennogen Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azapress 50mg tablets (Ennogen Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Is a Product containing precisely azathioprine 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has active ingredient Azathioprine false Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has specific active ingredient Azathioprine true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Azapress 50mg tablets (Ennogen Pharma Ltd) Is a Azapress true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Azapress 50mg tablets (Ennogen Pharma Ltd) 56 tablet 2 x 28 tablets Has AMP True Azapress 50mg tablets (Ennogen Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start